The Lancet: Additional support for OCT in diagnosis
The Lancet: Additional support for OCT in diagnosis
Retinal Asymmetry in Multiple Sclerosis
https://papers.ssrn.com/sol3/papers.cfm ... id=3463311
Background: The diagnosis of multiple sclerosis (MS) is based on a combination of clinical and para-clinical tests. The potential contribution of retinal optical coherence tomography (OCT) has been recognised. We tested the feasibility of OCT measures of retinal asymmetry as a diagnostic test for MS at the community level.
Method: In this community based study on 62,180 subjects we examined the diagnostic potential of the inter-eye difference of inner retinal OCT data for MS using the UK Biobank data collected at 22 sites between 2007-2010. The APOSTEL guidelines were followed for reporting automated retinal layer segmentation data and quality control. The inter-eye percentage difference (IEPD) and inter-eye absolute difference (IEAD) were calculated for the macular retinal nerve fibre layer (mRNFL), ganglion-cell inner plexiform layer complex (mGCIPL) and ganglion cell complex (mGCC). Area under the receiver operating characteristic curve (AUC) comparisons were followed by univariate and multivariable comparisons accounting for a large range of diseases and comorbidities. Cutoff levels were optimised by ROC and the Youden index.
Findings: The prevalence of MS was 0.0027 (95%CI 0.0023-0.0031). Overall the discriminatory power of diagnosing MS with the IEPD (AUC 0.71, 95%CI 0.67-0.76) and IEAD (0.71, 95%CI 0.66-0.75) for the mGCIPL were significantly higher if compared to the mGCC (IEPD AUC 0.66, 95%CI 0.62-0.71, p<0.05; IEAD AUC 0.64, 95%CI 0.60-0.68, p<0.001) and mRNFL (IEPD AUC 0.58, 95%CI 0.54-0.62, p<0.0001; IEAD AUC 0.54, 95%CI 0.50-0.58, p<0.0001). Screening sensitivity levels for the mGCIPL IEPD (4% cut-off) were 91.5% and for the IEAD (4 μm cut-off) 92.1%. Specificity levels were 18.3% and 17.3%. The number of comorbidities was important. There was a stepwise decrease of the AUC from 0.74 in healthy controls to 0.65 in more than nine comorbidities. In the multivariable analyses greater age, diabetes mellitus and a non-white ethnic background were relevant confounders.
Interpretation: The OCT GCIPL IEPD and IEAD should be considered as a supportive measurements for MS diagnostic criteria in a young person without relevant co-morbidity. Retinal OCT imaging is accurate, rapid, non-invasive, widely available and may therefore help to reduce need for invasive and more costly procedures. To be viable, higher sensitivity and specificity levels are needed. This may be achieved with artificial intelligence-based approaches incorporating inter-eye retinal asymmetry.
-
- Similar Topics
- Replies
- Views
- Last post
-
-
The lancet. Open call for using NFL in diagnosis and monitoring
by frodo » Thu Jun 25, 2020 1:26 am » in MS Etiology and Pathogenesis - 1 Replies
- 199 Views
-
Last post by frodo
Tue Jul 21, 2020 1:29 am
-
-
- 1 Replies
- 176 Views
-
Last post by Zyklon
Mon May 18, 2020 3:37 pm
-
- 3 Replies
- 981 Views
-
Last post by jimmylegs
Thu Jul 18, 2019 8:21 am
-
-
Immunoglobulin G analysis for diagnosis of MS
by frodo » Tue Feb 05, 2019 11:49 pm » in MS Etiology and Pathogenesis - 0 Replies
- 464 Views
-
Last post by frodo
Tue Feb 05, 2019 11:49 pm
-
-
- 7 Replies
- 2069 Views
-
Last post by vesta
Sat Mar 09, 2019 2:26 am
-
-
Four antioxidant biomarkers predict MS diagnosis
by frodo » Tue Jan 28, 2020 6:54 am » in MS Etiology and Pathogenesis - 0 Replies
- 1099 Views
-
Last post by frodo
Tue Jan 28, 2020 6:54 am
-
-
-
Seeking feedback on Ocrevus for PPMS, esp. from those 10-30 years POST DIAGNOSIS
by jab54 » Wed Feb 20, 2019 2:15 pm » in Ocrevus (Ocrelizumab) - 7 Replies
- 3030 Views
-
Last post by Optimistic99
Thu May 16, 2019 2:53 pm
-